Webinars Banner Image

Community Education Webinars

In partnership with The ALS Association, NEALS offers a variety of educational webinars for the ALS community.

Webinar topics include updates on clinical trials, best practices for clinical care, and current research efforts in ALS causes and treatments. Our webinars also offer participants the opportunity to ask questions directly of the experts running clinical trials and conducting research activities.
Neals logo
Mexiletine for Patients with Sporadic ALS 1-11-13 Screen Grab

Mexiletine for Patients with Sporadic ALS 1-11-13

Michael Weiss, MD (University of Washington) provided study rationale and background for the clinical trial of Mexiletine in patients with sporadic ALS (non-familial).  

Resistance and Endurance Exercise in ALS Trial Webinar 9-11-12 Screen Grab

Resistance and Endurance Exercise in ALS Trial Webinar 9-11-12

Nicholas Maragakis, MD (Johns Hopkins University) presented rationale for the Exercise Trial in ALS, which is recruiting patients with ALS in Baltimore, Boston, St. Louis, and Charlotte, NC and includes an at-home exercise…

Upper Motor Neuron Disease Research Webinar 7-2-12 Screen Grab

Upper Motor Neuron Disease Research Webinar 7-2-12

Hiroshi Mitsumoto, MD (Columbia University) and Nazem Atassi, MD, MMSc, (Massachusetts General Hospital, Harvard Medical School) presented their research initiatives for people with early Upper Motor Neuron Disease (UMD) and Primary…

Imaging Biomarkers Research Webinar 4-16-12 Screen Grab

Imaging Biomarkers Research Webinar 4-16-12

Nazem Atassi, MD, MMSc, (Massachusetts General Hospital, Harvard Medical School) and James Berry, MD, MPH, (Massachusetts General Hospital, Harvard Medical School) discussed the importance of biomarkers research and highlighted ongoing…

Clinical Trial Design Webinar 3-20-12 Screen Grab

Clinical Trial Design Webinar 3-20-12

Jeremy Shefner, MD, PhD, (SUNY Upstate Medical University) held an informational webinar providing a detailed background on trial design, including: process, expectations of phases, and the challenges of drug development.